axicabtagene ciloleucel
gilead,daiichi sankyo
['axi-cel']
findings also suggest that the durable response to car t-cell is actually driven by the recruited non-car t-cells (native t cells) after infusion.
definitely interesting area of research #ash22 
Oncology / Hematology and SCT Clinical Pharmacist @NGHAnews | Alum @UICPharm @BrighamWomens